{"id":90638,"date":"2025-09-28T11:21:08","date_gmt":"2025-09-28T11:21:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/90638\/"},"modified":"2025-09-28T11:21:08","modified_gmt":"2025-09-28T11:21:08","slug":"this-natural-compound-could-protect-the-brain-against-stroke","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/90638\/","title":{"rendered":"This Natural Compound Could Protect the Brain Against Stroke"},"content":{"rendered":"<p>\t\t<a href=\"https:\/\/scitechdaily.com\/images\/Human-Head-Anatomy-Stroke-Illustration.jpg\" rel=\"nofollow noopener\" target=\"_blank\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-192391 size-large\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/09\/Human-Head-Anatomy-Stroke-Illustration-777x583.jpg\" alt=\"Human Head Anatomy Stroke Illustration\" width=\"777\" height=\"583\"  \/><\/a>Early evidence hints that DMT can stabilize the blood\u2013brain barrier and dampen inflammation after stroke, likely via Sigma-1 receptors. Credit: Stock<\/p>\n<p><strong>A natural compound present in the brain shows promise in reducing stroke damage by protecting the blood-brain barrier and lowering inflammation.<\/strong><\/p>\n<p>DMT, short for dimethyltryptamine, is a naturally occurring psychoactive compound that exists in a variety of plants and animals.<\/p>\n<p>A recent study published in Science Advances by researchers at the HUN-REN BRC Institute of Biophysics and the Semmelweis University Heart and Vascular Centre reports that DMT can lessen the damaging impact of stroke in both laboratory cell cultures and animal models.<\/p>\n<p>A solution from nature in the spotlight<\/p>\n<p>This compound is also produced in the human brain, where it is now being investigated in clinical trials as a potential aid for restoring brain function following stroke. Until recently, the way DMT worked in this context remained unclear. \u201cIt is amazing how we can always turn to nature to find ingenious solutions for health problems,\u201d says co-lead author M\u00e1ria Deli from the HUN-REN BRC.<\/p>\n<p><a href=\"https:\/\/scitechdaily.com\/images\/Anna-Kocsis-Zsofia-Hoyk-Maria-Deli-Fruzsina-Walter-and-Judit-Vigh.jpg\" rel=\"nofollow noopener\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"size-large wp-image-496369\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/09\/Anna-Kocsis-Zsofia-Hoyk-Maria-Deli-Fruzsina-Walter-and-Judit-Vigh-777x508.jpg\" alt=\"Anna Kocsis, Zs\u00f3fia Hoyk, M\u00e1ria Deli, Fruzsina Walter and Judit Vigh\" width=\"777\" height=\"508\"  \/><\/a>Co-authors of the study from the Biological Barriers Research Group of the Institute of Biophysics, HUN-REN BRC Szeged (from left to right: Anna Kocsis, Zs\u00f3fia Hoyk, M\u00e1ria Deli, Fruzsina Walter, Judit Vigh). Credit: Fruzsina Walter<br \/>\nThe blood-brain barrier as a therapeutic target<\/p>\n<p>\u201cWe found that DMT significantly reduced infarct volume and edema formation in a rat stroke model,\u201d explains co-first author Marcell L\u00e1szl\u00f3. In both animal experiments and cell culture models, the authors showed that DMT treatment restored the structure and function of the damaged blood-brain barrier and improved the function of astroglial cells.<\/p>\n<p>This psychoactive compound also inhibited the production of inflammatory cytokines in brain endothelial cells and peripheral immune cells, while reducing the activation of brain microglia cells through Sigma-1 receptors.<\/p>\n<p>DMT could serve as therapeutic adjuvant to existing stroke treatments<\/p>\n<p>\u201cThe therapeutic options currently available for stroke are very limited. The dual action of DMT, protecting the blood-brain barrier while reducing brain inflammation, offers a novel, complex approach that could complement existing treatments,\u201d says Judit Vigh, co-first author of the work.<\/p>\n<p>Since current stroke therapies do not always result in full recovery, a DMT-based treatment may represent a promising new alternative, mainly in combination with existing methods. The recent findings from researchers in Szeged and Budapest, Hungary, support the development of a therapy that goes beyond the limitations of conventional stroke treatment. Clinical trials on the use of DMT and investigations on its long-term effects are currently ongoing.<\/p>\n<p>Reference: \u201cN,N-dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation\u201d by Marcell J. L\u00e1szl\u00f3, Judit P. Vigh, Anna E. Kocsis, Gerg\u0151 Porkol\u00e1b, Zs\u00f3fia Hoyk, Tam\u00e1s Polg\u00e1r, Fruzsina R. Walter, Attila Szab\u00f3, Srdjan Djurovic, B\u00e9la Merkely, Al\u00e1n Alp\u00e1r, Ede Frecska, Zolt\u00e1n Nagy, M\u00e1ria A. Deli and S\u00e1ndor Nardai, 13 August 2025, Science Advances.<br \/><a href=\"https:\/\/doi.org\/10.1126\/sciadv.adx5958\" rel=\"nofollow noopener\" target=\"_blank\">DOI: 10.1126\/sciadv.adx5958<\/a><\/p>\n<p><b>Never miss a breakthrough: <a href=\"https:\/\/scitechdaily.com\/newsletter\/\" rel=\"nofollow noopener\" target=\"_blank\">Join the SciTechDaily newsletter.<\/a><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"Early evidence hints that DMT can stabilize the blood\u2013brain barrier and dampen inflammation after stroke, likely via Sigma-1&hellip;\n","protected":false},"author":2,"featured_media":90639,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[78],"tags":[159,18,135,19,99,17,1867,3267,6425],"class_list":{"0":"post-90638","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-brain","9":"tag-eire","10":"tag-health","11":"tag-ie","12":"tag-inflammation","13":"tag-ireland","14":"tag-molecular-biology","15":"tag-neurology","16":"tag-stroke"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/90638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=90638"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/90638\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/90639"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=90638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=90638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=90638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}